TSE:6724
TSE:6724Tech

Did New Bose-Enhanced Projectors and Labeling Tech Just Shift Seiko Epson's (TSE:6724) Investment Narrative?

Epson announced a new lineup of Lifestudio projectors featuring Sound by Bose technology and its latest 3LCD projection advances, alongside plans to showcase its ColorWorks on-demand color labeling solutions at PACK EXPO Las Vegas. This dual move highlights Epson's commitment to innovation in both entertainment hardware and industrial printing, signaling an effort to capture diverse growth opportunities across consumer and business markets. We'll examine how the introduction of projectors...
TSE:9501
TSE:9501Electric Utilities

Is Tokyo Electric Power (TSE:9501) Undervalued? A Fresh Look at Its Market Valuation

Tokyo Electric Power Company Holdings (TSE:9501) has been generating some buzz lately, and for good reason. Even in the absence of a single headline event, recent shifts in the stock's performance are drawing attention from investors considering whether now is the right time to act. When a utility giant like this moves, it often prompts questions such as whether something has changed under the hood or if the market is simply starting to rethink its valuation. Looking at the bigger picture,...
TSE:6856
TSE:6856Electronic

Should You Reassess HORIBA Shares After Another Double Digit Surge in 2025?

If you are wondering what to do with HORIBA’s stock right now, you are not alone. Investors have been watching closely as the share price keeps climbing, and the conversation has shifted from “is it a good company” to “is it a good price.” In just the past week, HORIBA shares have risen 4.9%, building on a 13.4% jump over the past month. The momentum looks even more impressive when you zoom out: a 40.8% gain year to date, 42.1% over the past year, and a substantial 145.6% return in three...
TSE:5332
TSE:5332Building

Should You Reconsider TOTO After Its Recent 6% Monthly Rally in 2025?

If you are weighing what to do with TOTO stock right now, you are not alone. After a bumpy year, TOTO’s price has recently started to rebound, sparking fresh debates about its future prospects and whether it is truly undervalued or still a risky bet. Over the past seven days, the stock dipped slightly by 1.3%, but zoom out to one month and TOTO shows a healthy 6.1% jump. This mild rally comes despite market sentiment still being cautious after a longer-term drop. The stock remains down more...
TSE:6532
TSE:6532Professional Services

Is Now the Right Moment to Reassess Baycurrent Shares After 13.5% Valuation Gap?

If you have been wondering what to do with your Baycurrent shares lately, or are eyeing the stock from the sidelines, you are in good company. Over just the last week, Baycurrent shares jumped 4.5%, adding to a string of strong returns: up 3.5% in the past month, a remarkable 64.6% year-to-date, and a staggering 73.6% in the last year alone. Even zooming out over five years reveals a 546.3% gain. That kind of performance turns heads, and for good reason. The upward momentum is more than just...
TSE:6525
TSE:6525Semiconductor

Kokusai Electric (TSE:6525) Valuation in Focus as KKR's Lock-Up Expiry Raises Secondary Sale Prospects

Kokusai Electric (TSE:6525) is suddenly in the spotlight as KKR’s lock-up period is set to expire in just three weeks, opening the door for a possible $700 million share sale. If you hold the stock or are considering jumping in, this pending event is more than just corporate news. It could shake up the supply-demand balance, with traders watching closely to see how much, if any, of the overhang hits the open market. This comes after a whirlwind ascent in Kokusai Electric’s share price, which...
TSE:3092
TSE:3092Specialty Retail

Does the Market Expect Too Much From ZOZO After Its Recent Revenue Forecast Cut?

If you have been tracking ZOZO stock recently, you have likely noticed it has not exactly been a smooth ride. The share price closed at 1,422.0, and over the past week and month, it has slipped by -2.0%, continuing a downward trend that stretches to -10.9% year-to-date and over the past twelve months as well. But step back and you will see that longer-term holders have still enjoyed solid gains, with shares up 54.1% over three years and 61.9% over five years. These are clear signs this isn’t...
TSE:7956
TSE:7956Household Products

Should Investors Reassess Pigeon After 18% Discount to DCF Value in 2025?

Deciding what to do with Pigeon stock right now probably feels like choosing between optimism and caution. After years in the spotlight, this company has had a turbulent ride: up almost 25% year to date but still down a staggering 54.3% over the past five years. Recent weeks have seen some hesitation in the market, with the price slipping by 2.4% over the last week and 3.6% across the past month. When the big picture seems so mixed, it is natural to wonder if today's price represents an...
TSE:2121
TSE:2121Entertainment

Does MIXI’s 19% Surge in 2024 Signal More Potential Ahead?

If you have been eyeing MIXI’s stock lately, you’re not alone. With plenty of chatter swirling around tech stocks and a clear jump in investor interest, MIXI has undeniably grabbed attention. Over the past year, the stock is up an impressive 18.9%. Stretch that out to three years and you are looking at a hefty 59.5% gain, which is no small feat in any market climate. Sure, the last month (+0.3%) and last week (-1.3%) have been pretty tame, but it is the company’s strong longer-term momentum...
TSE:4506
TSE:4506Pharmaceuticals

How Investors May Respond To Sumitomo Pharma (TSE:4506) Gaining FTSE All-World Index Inclusion

Sumitomo Pharma Co., Ltd. (TSE:4506) was recently added to the FTSE All-World Index (USD), broadening its profile among global investors. This index inclusion often increases exposure to passive investment funds and may lead to shifts in the company's shareholder base. We'll examine how greater index exposure could influence Sumitomo Pharma's investment narrative and market positioning. AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug...